BENZAZEPINE DERIVATIVES USEFUL FOR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES
申请人:Brian Smith
公开号:US20130172322A1
公开(公告)日:2013-07-04
The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
本发明涉及某些1-取代-2,3,4,5-四氢-3-苯并哌啶衍生物,其为5HT2C受体调节剂。因此,本发明化合物对于预防或治疗与5HT2C受体相关的疾病、病况或障碍,如肥胖症及相关疾病,是有用的。